Effect of lipopolysaccharide on angiotensin II type 1 receptor expression and function in human pulmonary microvascular endothelial cells

Li,Hong‑Peng; Qiu,Hai‑Bo; Wang,Hai‑Qin

doi:10.3892/mmr.2015.4481

Effect of lipopolysaccharide on angiotensin II type 1 receptor expression and function in human pulmonary microvascular endothelial cells

Authors:
- Hong‑Peng Li
- Hai‑Bo Qiu
- Hai‑Qin Wang
View Affiliations

Affiliations: Department of Critical Care Medicine, Zhongda Hospital Affiliated to Southeast University, Nanjing, Jiangsu 210009, P.R. China, Department of Health Service Management, School of Public Health, Fudan University, Shanghai 200433, P.R. China
Published online on: October 23, 2015 https://doi.org/10.3892/mmr.2015.4481
Pages: 8289-8293

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Lipopolysaccharides (LPSs) are an important initiation factor in acute respiratory distress syndrome. The aim of the present study was to investigate the effect of LPSs on the regulation of angiotensin II (Ang II) receptors in human pulmonary microvascular endothelial cells (HPMECs). HPMECs were treated with 0, 50, 100 or 200 ng/ml LPS and incubated for 4, 8, 12 or 16 h. The expression of Ang II type 1 receptor (AT1R) and Ang II type 2 receptor (AT2R) was determined using reverse transcription‑polymerase chain reaction and western blot analysis. The affinity to Ang II was measured using a radioligand binding assay. No AT2R expression was detected with or without LPS administration in HPMECs, and LPS treatment increased the expression level of AT1R. A time‑dependent increase of AT1R transcription was observed in the 50 ng/ml group, while in the 100 and 200 ng/ml groups, the AT1R mRNA levels reached peak values at 4 h and remained unchanged. The protein level of AT1R increased significantly in a dose‑dependent manner for each incubation time period. A time‑dependent increase in the protein level was observed in the 50 and 100 ng/ml groups. As for the 200 ng/ml group, the level of AT1R reached a peak value at 8 h. Maximal binding (Bmax) significantly increased following LPS treatment and Bmax of the 50 ng/ml group exhibited a time‑dependent increase. The Bmax of the 100 and 200 ng/ml groups reached peak values at 12 and 8 h, respectively, and decreased thereafter. The dissociation constant remained unchanged following LPS treatment. Thus, treatment with LPS increased AT1R expression and its Bmax to Ang II in HPMECs, however, did not alter the affinity of AT1R to Ang II.

View Figures

View References

1	Li JS, Touyz RM and Schiffrin EL: Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats. Hypertension. 31:487–492. 1998. View Article : Google Scholar : PubMed/NCBI
2	Griendling KK and Ushio-Fukai M: Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept. 91:21–27. 2000. View Article : Google Scholar : PubMed/NCBI
3	Zhang H, Schmeisser A, Garlichs CD, Plötze K, Damme U, Mügge A and Daniel WG: Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: Role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res. 44:215–222. 1999. View Article : Google Scholar
4	Ruiz-Ortega M, Lorenzo O, Ruperez M, König S, Wittig B and Egido J: Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: Molecular mechanisms. Circ Res. 86:1266–1272. 2000. View Article : Google Scholar : PubMed/NCBI
5	Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, McAnulty RJ and Laurent GJ: Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol. 286:L156–L164. 2004. View Article : Google Scholar
6	Marshall RP, McAnulty RJ and Laurent GJ: Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor. Am J Respir Crit Care Med. 161:1999–2004. 2000. View Article : Google Scholar : PubMed/NCBI
7	Bechara RI, Pelaez A, Palacio A, Joshi PC, Hart CM, Brown LA, Raynor R and Guidot DM: Angiotensin II mediates glutathione depletion, transforming growth factor-beta1 expression and epithelial barrier dysfunction in the alcoholic rat lung. Am J Physiol Lung Cell Mol Physiol. 289:L363–L370. 2005. View Article : Google Scholar : PubMed/NCBI
8	Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, et al: Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 436:112–116. 2005. View Article : Google Scholar : PubMed/NCBI
9	Idell S, Kueppers F, Lippmann M, Rosen H, Niederman M and Fein A: Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. Chest. 91:52–56. 1987. View Article : Google Scholar : PubMed/NCBI
10	Brasier AR, Recinos A III and Eledrisi MS: Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol. 22:1257–1266. 2002. View Article : Google Scholar : PubMed/NCBI
11	Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, et al: Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest. 101:527–535. 1998. View Article : Google Scholar : PubMed/NCBI
12	Zhang H and Sun GY: Expression and regulation of AT1 receptor in rat lung microvascular endothelial cell. J Surg Res. 134:190–197. 2006. View Article : Google Scholar : PubMed/NCBI
13	Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR and English D: Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest. 108:689–701. 2001. View Article : Google Scholar : PubMed/NCBI
14	Birukova AA, Wu T, Tian Y, Meliton A, Sarich N, Tian X, Leff A and Birukov KG: Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury. Eur Respir J. 41:165–176. 2013. View Article : Google Scholar :
15	Li H, Qiu H, Xu D, Liu L, Wang L, Dig H, Yang Y and Zhou S: Establishment of radioligand binding assay for angiotensin II type 1 receptor of human pulmonary microvascular endothelial cell after lipopolysaccharide stimulation. Int J Respir. 27:1761–1764. 2007.
16	Dincer HE, Gangopadhyay N, Wang R and Uhal BD: Norepinephrine induces alveolar epithelial apoptosis mediated by alpha-, beta- and angiotensin receptor activation. Am J Physiol Lung Cell Mol Physiol. 281:L624–L630. 2001.PubMed/NCBI
17	Li X, Shu R, Filippatos G and Uhal BD: Apoptosis in lung injury and remodeling. J Appl Physiol (1985). 97:1535–1542. 2004. View Article : Google Scholar
18	Chan LY, Leung JC, Tang SC, Choy CB and Lai KN: Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy. J Am Soc Nephrol. 16:2306–2317. 2005. View Article : Google Scholar : PubMed/NCBI
19	Li JY, Avallet O, Berthelon MC, Langlois D and Saez JM: Transcriptional and translational regulation of angiotensin II type 2 receptor by angiotensin II and growth factors. Endocrinology. 140:4988–4994. 1999.PubMed/NCBI
20	Raiden S, Nahmod K, Nahmod V, Semeniuk G, Pereira Y, Alvarez C, Giordano M and Geffner JR: Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome. J Pharmacol Exp Ther. 303:45–51. 2002. View Article : Google Scholar : PubMed/NCBI
21	Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M and Saruta T: Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension. 30:35–41. 1997. View Article : Google Scholar : PubMed/NCBI
22	Li D, Yang B, Philips MI and Mehta JL: Proapoptotic effects of ANG II in human coronary artery endothelial cells: Role of AT1 receptor and PKC activation. Am J Physiol. 276:H786–H792. 1999.PubMed/NCBI
23	Trowbridge IS, Collawn JF and Hopkins CR: Signal-dependent membrane protein trafficking in the endocytic pathway. Annu Rev Cell Biol. 9:129–161. 1993. View Article : Google Scholar : PubMed/NCBI
24	Mukherjee S, Ghosh RN and Maxfield FR: Endocytosis. Physiol Rev. 77:759–803. 1997.PubMed/NCBI
25	Marsh M and McMahon HT: The structural era of endocytosis. Science. 285:215–220. 1999. View Article : Google Scholar : PubMed/NCBI